Classification of pancreatic cancer
According to the site of occurrence of pancreatic cancer can be divided into pancreatic head cancer, pancreatic body cancer, pancreatic cancer and the whole tail pancreatic cancer.
1), pancreatic head cancer: pancreatic head, including the nipple and bile duct bottom, so there are pancreatic head cancer, papillary carcinoma, ampullary carcinoma and bile duct cancer, and so the bottom of the name of difference. According to statistics, pancreatic cancer occurred in the pancreatic head were about 60% to 70%, with an average size of 4.2 ~ 5.7cm. May be engaging in sexual oppression common bile duct Erzhi obstructive jaundice, gall bladder and liver enlargement; such as infiltration of bile duct cancer or ampullary erosion occurs, can cause both acute and chronic hemorrhage; can arise due to enlargement of the liver bile stasis. Most of conduct into the jaundice, weight loss, upper abdominal pain or fullness discomfort, pain, usually located on the abdomen or the right, may apply to the shoulder of radiation.
2) The pancreatic body cancer, pancreatic tail carcinoma: pancreatic body and tail can not be a clear line between classified and therefore collectively referred to as pancreatic body and tail cancer. Pancreatic cancer occurred in the pancreatic body and tail were only 30%. Pancreatic body and tail cancer, the organization can damage arising from diabetes, insulin, and can be associated with peripheral venous thrombosis caused by splenomegaly, portal hypertension embolism may be due to tumor secretion of a substance to promote blood coagulation due. Pancreatic body and tail cancer metastasis compared with pancreatic head carcinoma is the early and more common and extensive, and can be transferred to the regional lymph nodes, liver, peritoneum and lungs.
3) Full of pancreatic cancer: pancreatic widely known as cancer, may be the head of pancreas, pancreatic body, pancreatic cancer, further development of the tail can also be an early stage of diffuse disease. Gejia report its incidence vary, accounting for about 10% of pancreatic cancer.
